SCALZO RICHARD WILLIAM (Chief Financial Officer) sold 2.8% of their position (568.00 shares) of CRESCENT BIOPHARMA, INC. on the open market
Open‑market sale worth $10.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/18/2026ACC: 0001628280-26-062705
Officer· Chief Financial Officer
Since Jun 2025
-568.00
Net shares
Net seller
$10.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
568.00 disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−568.00
Price / share
$17.90
Trade value
$10.17K
% of position
2.8%
9/16/2026
20.30K→19.73K
Total
Net shares
−568.00
Net value
-$10.17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 9/16/2026 | S · Sale | −568.00 | $17.90 | $10.17K | 2.8% | 20.30K | 19.73K |
| Total | −568.00 | -$10.17K | ||||||
Derivative Transactions0
No derivative transactions reported